Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site digital illustration

Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site Save


ICD-10 code: C81.00

Disease category: C81.0: Nodular lymphocyte predominant Hodgkin lymphoma

Nodular Lymphocyte Predominant Hodgkin Lymphoma, Unspecified Site

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma characterized by unique clinical and pathological features. Unlike classic Hodgkin lymphoma, NLPHL is primarily found in the lymph nodes and typically affects younger individuals. This article provides an overview of NLPHL, its symptoms, diagnosis, and prognosis.

  1. Symptoms: NLPHL often presents with painless swelling of lymph nodes, commonly in the neck, armpits, or groin. Fatigue, fever, night sweats, and unintended weight loss are other possible symptoms. However, it's important to note that NLPHL is generally less aggressive than other forms of Hodgkin lymphoma.
  2. Diagnosis: To diagnose NLPHL, a thorough physical examination is conducted, followed by imaging tests such as CT scans or PET scans. A biopsy of the affected lymph node is then performed to analyze the cellular composition and detect the presence of specific markers, such as CD20 and CD45, which are characteristic of NLPHL.
  3. Pathology: NLPHL is characterized by the presence of nodules, or "popcorn cells," which are large, pale-staining lymphocytes with prominent nucleoli. These nodules are surrounded by a background of small, non-malignant lymphocytes. Unlike classic Hodgkin lymphoma, NLPHL lacks Reed-Sternberg cells, a hallmark of the former.
  4. Prognosis: NLPHL generally has a favorable prognosis, with a higher overall survival rate compared to classic Hodgkin lymphoma. The disease progresses slowly, and most patients respond well to treatment. However, long-term follow-up is necessary to monitor for potential relapse or transformation into a more aggressive form.

It's important to consult with a medical professional for an accurate diagnosis and appropriate management of NLPHL. Treatment options may include watchful waiting, radiation therapy, or in some cases, targeted therapies. The choice of treatment depends on various factors, including the stage of the disease, the patient's overall health, and individual preferences.

In conclusion, Nodular Lymphocyte Predominant Hodgkin Lymphoma is a distinct subtype of Hodgkin lymphoma that primarily affects the lymph nodes. Recognizing its unique features, such as "popcorn cells" and the absence of Reed-Sternberg cells, is crucial for accurate diagnosis. While NLPHL generally has a favorable prognosis, ongoing monitoring and appropriate medical care are essential for optimal management.

Treatment of Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site:

Treatment Options for Nodular Lymphocyte Predominant Hodgkin Lymphoma, Unspecified Site

Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) is a rare type of Hodgkin lymphoma that differs from classical Hodgkin lymphoma both clinically and pathologically. When diagnosed with NLPHL, it is important to understand the available treatment options to make informed decisions regardin...

To see full information about treatment please Sign up or Log in